Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,148 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06001047Recruiting
Head acupuncture for BPPV residual symptoms
This study tests whether head acupuncture can help with lingering symptoms (like unsteadiness or discomfort) that sometimes remain after a successful repositioning procedure for BPPV, a common cause of vertigo. If you feel better but not fully steady, this treatment might help.
Xi'anAges 18–65 - NCT04628416Recruiting
Negative-pressure dressing test for fibula flap donor skin graft
This trial studies whether a special suction dressing (negative pressure) helps healing at the skin-graft donor site for people getting a fibula free flap. It may reduce complications and improve how the graft takes, compared with standard care.
MontpellierAges 18 years+ - NCT06173986RecruitingPhase 1/Phase 2
Immunotherapy plus chemoradiation for advanced esophageal cancer
This trial tests whether adding immunotherapy to standard chemoradiation can help people with unresectable locally advanced esophageal cancer. It aims to improve outcomes for those who cannot have surgery.
ShanghaiAges 18–75 - NCT05426252RecruitingPhase 1/Phase 2
Lower-toxicity bone marrow conditioning for high-risk thalassemia
This trial tests a modified, lower-toxicity preparation (conditioning) before a bone marrow transplant in children and teens with high-risk thalassemia. It aims to reduce treatment side effects while still allowing transplant success for people who need a donor.
Toronto, OntarioAges 1–18 - NCT06001086RecruitingPhase 2
Disitamab Vedotin plus Pyrotinib for HER2-positive early breast cancer
This trial tests a combination of two targeted drugs (Disitamab Vedotin and Pyrotinib) for people with HER2-positive early breast cancer. It aims to see if this treatment can improve outcomes before standard therapy.
Nanjing, JiangsuAges 18 years+ - NCT06177015RecruitingPhase 3
Darolutamide with chemo for metastatic prostate cancer
This trial tests a new way of using darolutamide (a hormone therapy) together with standard chemotherapy (docetaxel) and hormone therapy (ADT) for men with prostate cancer that has spread. The goal is to see if taking darolutamide on an intermittent schedule works as well as continuous treatment.
Nanjing, JiangsuAges 40–80 - NCT04084938Recruiting
Clot-blocking treatment versus surgery for enlarged prostate
This trial compares artery embolization (blocking blood flow to the prostate) with standard surgery for urinary symptoms caused by an enlarged prostate. It may help patients who have moderate-to-severe bladder outlet symptoms and are looking for a treatment option when medicine didn’t work (or they don’t want medicine).
OsloAges Any age - NCT04916197RecruitingPhase 4
Dexmedetomidine sedation after stroke clot removal
This Phase 4 study tests whether using a specific calming medicine (dexmedetomidine) for a longer period after a successful clot-removal procedure helps people do better in the long term. It may help improve outcomes after ischemic stroke where the clot is successfully treated.
Beijing, Beijing MunicipalityAges 18–80 - NCT07854951Recruiting
Hypnosis for pain and nausea relief in scoliosis surgery
This trial tests if hypnosis can reduce pain and nausea after scoliosis surgery. Adolescents aged 12-18 who are having scoliosis surgery may be eligible to participate.
TrondheimAges 12–18 - NCT06654414Recruiting
Smoking cessation support for transgender and gender-diverse adults
This study tests a skills-based program to help transgender and gender-diverse adults quit smoking or vaping. The program focuses on managing stress related to identity and health, and may be more supportive than standard quit programs.
Boston, MassachusettsAges 18 years+ - NCT07428785Recruiting
Measuring lung and blood volume in COPD
This study looks at how COPD affects the amount of air your lungs can hold and the total blood in your body. The goal is to better understand the disease, which may help improve future treatments.
CopenhagenAges 45–80 - NCT07856537Recruiting
Timing of complications after surgery in the first day in intensive care
This study watches patients for the first 24 hours after they move to an intensive care unit (ICU) following surgery. It tracks when complications happen during that time to help improve care.
IstanbulAges 18 years+ - NCT06177509Recruiting
Exercise therapy for mild traumatic brain injury
This trial tests if graded aerobic exercise can help people who have ongoing symptoms after a mild traumatic brain injury (concussion). It aims to see if carefully increasing exercise intensity improves tolerance to physical activity.
NesoddtangenAges 18–60 - NCT05382403Recruiting
Vacuum device for heavy bleeding after childbirth
This study looks at a vacuum-based device to help stop severe bleeding after delivery (postpartum hemorrhage), especially when the uterus is not tightening. It may help women who have ongoing bleeding despite standard first medicines to reduce bleeding.
Kumasi, Ashanti RegionAges 18–44 - NCT05995106Recruiting
Mobile app for high blood pressure in pregnancy
This study tests a mobile health app to help manage high blood pressure during pregnancy. It's for pregnant women 18+ with high blood pressure or at high risk, who can use a smartphone.
Seongnam-si, Gyeonggi-doAges 18 years+ - NCT04732546Recruiting
Study of reproductive health in women with uterine variations
This study looks at how certain uterine (womb) variations affect diagnosis, treatment choices, and reproductive outcomes. It may help doctors better understand these conditions and improve care for affected women.
Ghent, East FlandersAges Up to 45 years - NCT04993469Recruiting
Tracking genital comfort after gender-affirming surgery
This study asks people who are planning genital gender-affirming surgery to report how their genital sensitivity and sexual function feel afterward. It helps doctors understand what changes patients experience and improve follow-up care.
Ghent, East-FlandersAges 18–110 - NCT05245487Recruiting
Study of blood samples in older people with relapsed lymphoma
This study looks at blood (“hematopoietic”) information in people age 60+ with relapsed B-cell non-Hodgkin lymphoma who need an additional round of treatment. It may help researchers understand changes in the body during active lymphoma therapy.
CopenhagenAges 60 years+ - NCT05833594Recruiting
Immunonutrition plus chemoradiation for unresectable esophageal cancer
This trial studies whether adding an “immunonutrition” nutrition plan to standard chemoradiation can improve outcomes for people with locally advanced, unresectable esophageal squamous cell cancer. It may help the treatment work better by supporting the immune system during therapy.
HefeiAges 18–85 - NCT05063955Recruiting
Study muscle changes in people with heart failure
This study looks at the reasons for age-related muscle loss (sarcopenia) in people with heart failure. It may help researchers understand what is causing muscle weakness and how it could be treated in the future.
Aarhus NAges 18–90 - NCT07859397Recruiting
Pain relief options for knee ligament surgery
This study compares two nerve-block approaches to see which provides better pain relief after knee ligament reconstruction surgery. If you are having this surgery, joining could help manage your pain more effectively.
AnkaraAges 18–65 - NCT06061146RecruitingPhase 2
Tislelizumab plus chemoradiation for older esophageal cancer patients
This trial tests a combination of an immunotherapy drug (tislelizumab) with chemotherapy and radiation for older adults (70+) with advanced esophageal cancer that hasn't been treated before. The goal is to see if this approach can help control the cancer while keeping quality of life.
Tianjin, Tianjin MunicipalityAges 70–90 - NCT05189054Recruiting
Radiation retreatment for very central chest tumors
This trial tests a focused form of radiation (SBRT) to treat tumors in the very center of the chest that have already been treated with radiation before. It aims to check safety and whether the tumor can be controlled without causing unacceptable side effects.
Beijing, Beijing MunicipalityAges 18–80 - NCT05349552Recruiting
Radiation for lung or chest cancers in specific locations
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
Beijing, Beijing MunicipalityAges 18–80
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,148 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.